Given this new paradigm of photocarcinogenesis involving dermal fibroblast senescence with resultant IGF-1 deficiency, therapeutics designed to prevent or treat fibroblast senesce could have use, especially in populations at high risk for skin cancer. Here, IGF1 is linked to skin neoplasm.